Raloxifene and/or estradiol decrease anxiety-like and depressive-like behavior, whereas only estradiol increases carcinogen-induced tumorigenesis and uterine proliferation among ovariectomized rats.

PubWeight™: 0.80‹?›

🔗 View Article (PMC 2885355)

Published in Behav Pharmacol on May 01, 2010

Authors

Alicia A Walf1, Cheryl Anne Frye

Author Affiliations

1: Department of Psychology, The University at Albany, State University of New York, Albany, NY 12222, USA.

Articles cited by this

The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet (1997) 10.28

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA (1999) 9.71

The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. JAMA (1999) 7.30

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med (1997) 6.15

The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc (2007) 4.51

Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice. N Engl J Med (2003) 3.46

Systematic review: comparative effectiveness of medications to reduce risk for primary breast cancer. Ann Intern Med (2009) 2.79

Roles of estrogen receptor-alpha gene expression in reproduction-related behaviors in female mice. Endocrinology (1998) 2.05

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer (1999) 1.98

A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology (2006) 1.90

Increased anxiety and synaptic plasticity in estrogen receptor beta -deficient mice. Proc Natl Acad Sci U S A (2001) 1.62

ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology (2005) 1.61

The membrane actions of estrogens can potentiate their lordosis behavior-facilitating genomic actions. Proc Natl Acad Sci U S A (2004) 1.59

Biomedicine. Defining the "S" in SERMs. Science (2002) 1.52

Tamoxifen, raloxifene, and the prevention of breast cancer. Endocr Rev (1999) 1.40

Antianxiety and antidepressive behavior produced by physiological estradiol regimen may be modulated by hypothalamic-pituitary-adrenal axis activity. Neuropsychopharmacology (2005) 1.32

Changes in progesterone metabolites in the hippocampus can modulate open field and forced swim test behavior of proestrous rats. Horm Behav (2002) 1.31

Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats. Pharmacol Biochem Behav (2006) 1.27

Experimentally induced mammary tumors in rats. Breast Cancer Res Treat (1996) 1.22

The neurosteroids, progesterone and 3alpha,5alpha-THP, enhance sexual motivation, receptivity, and proceptivity in female rats. Brain Res (1998) 1.18

Estrogen receptor beta regulates the expression of tryptophan-hydroxylase 2 mRNA within serotonergic neurons of the rat dorsal raphe nuclei. Neuroscience (2009) 1.12

Effects of raloxifene and estradiol on hippocampal acetylcholine release and spatial learning in the rat. Psychoneuroendocrinology (2004) 1.11

Estrogen action: a historic perspective on the implications of considering alternative approaches. Physiol Behav (2009) 1.07

Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats. Eur J Pharmacol (2001) 1.03

ERalpha, but not ERbeta, mediates the expression of sexual behavior in the female rat. Behav Brain Res (2008) 1.03

Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain. Neuropsychopharmacology (2001) 1.02

Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br J Cancer (1990) 1.02

Hormone-driven mechanisms in the central nervous system facilitate the analysis of mammalian behaviours. J Endocrinol (2005) 1.01

WAY-200070, a selective agonist of estrogen receptor beta as a potential novel anxiolytic/antidepressant agent. Neuropharmacology (2008) 1.00

Two principles in endocrine therapy of cancers: hormone deprival and hormone interference. Cancer Res (1965) 0.99

Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women. Psychoneuroendocrinology (1999) 0.96

Selective estrogen receptor modulators: a look ahead. Drugs (1999) 0.94

Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: a placebo-controlled randomized trial. Obstet Gynecol (2000) 0.93

Chemoprevention of breast cancer. Am J Health Syst Pharm (2008) 0.92

Ospemifene inhibits the growth of dimethylbenzanthracene-induced mammary tumors in Sencar mice. J Steroid Biochem Mol Biol (2005) 0.91

Effects of two estradiol regimens on anxiety and depressive behaviors and trophic effects in peripheral tissues in a rodent model. Gend Med (2009) 0.91

Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease. Exp Neurol (2004) 0.90

Raloxifene and estradiol benzoate both fully restore hippocampal choline acetyltransferase activity in ovariectomized rats. Brain Res (1999) 0.89

Menopausal hormone therapy. J Obstet Gynaecol Can (2005) 0.89

Administration of raloxifene reduces sensorimotor and working memory deficits following traumatic brain injury. Behav Brain Res (2006) 0.87

An expression study of hormone receptors in spontaneously developed, carcinogen-induced and hormone-induced mammary tumors in female Noble rats. Int J Oncol (2003) 0.87

Effects of SERM (selective estrogen receptor modulator) treatment on growth and proliferation in the rat uterus. Reprod Biol Endocrinol (2003) 0.86

Menopause and the menopausal transition. Med Clin North Am (2008) 0.85

Mood effect of raloxifene in postmenopausal women. Maturitas (2002) 0.84

Tamoxifen and raloxifene produce conditioned taste avoidance in female rats: a microstructural analysis of licking patterns. Life Sci (2008) 0.84

Influence of estrogen and progesterone on the induction of mammary carcinomas by 7,12-dimethylbenz(a)anthracene in ovariectomized rats. Virchows Arch B Cell Pathol Incl Mol Pathol (1992) 0.83

Estradiol enhances sociosexual behavior and can have proliferative effects in ovariectomized rats. Age (Dordr) (2008) 0.81

Effect of raloxifene on quality of life: a prospective study using the Utian Quality of Life (UQOL) Scale. Menopause (2004) 0.80

Recent advances in selective estrogen receptor modulators for breast cancer. Mini Rev Med Chem (2009) 0.80

Estrogen agonists/antagonists in combination with estrogen for prevention and treatment of menopause-associated signs and symptoms. Womens Health (Lond Engl) (2008) 0.79

Oestrogen receptor beta is involved in the actions of oestrogens in the brain for affective behaviour, but not trophic effects in peripheral tissues. J Neuroendocrinol (2009) 0.79

Sex hormone-induced mammary carcinogenesis in female Noble rats: detection of differentially expressed genes. Breast Cancer Res Treat (2003) 0.79

Hormonal environment in the induction of breast cancer in castrated rats using dimethylbenzanthracene: influence of the presence or absence of ovarian activity and of treatment with estradiol, tibolone, and raloxifene. Menopause (2005) 0.78

The selective estrogen receptor modulator, raloxifene: reproductive assessments in adult male rats. Reprod Toxicol (1998) 0.77

Estrogenic activity of tamoxifen and raloxifene on rat brain AMPA receptors. Neuroreport (2001) 0.77

The effects of raloxifen on depression and cognition in ovariectomized rats. Fertil Steril (2007) 0.76

Raloxifene effects upon the neuronal system controlling sexual receptivity in female rats. Neurosci Lett (2002) 0.76